NeoGenomics, Inc.
16.59USD
+0.2000 (+1.22%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on NEO.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.06▼ | $0.06 | 2 | 1 |
| Next quarter | $0.07▼ | $0.09 | 0 | 4 |
| Current year | $0.19▲ | $0.18 | 3 | 0 |
| Next year | $0.34▼ | $0.36 | 1 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.03 | $0.05 | +0.02 (+48.6%) |
| 2026-03-31 | $0 | $0.01 | +0.01 (+800.9%) |
| 2025-12-31 | $0.04 | $0.06 | +0.02 (+50.0%) |
| 2025-09-30 | $0.02 | $0.03 | +0.01 (+25.8%) |
153 ratings from 28 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| StoneX | Maintained | Buy | $16 $20 | Oct 6, 2026 |
| Needham | Maintained | Buy | $19 $22 | Oct 6, 2026 |
| BTIG | Upgraded from Neutral | Buy | $28 | Oct 6, 2026 |
| Needham | Maintained | Buy | $15 $19 | Jul 29, 2026 |
| Benchmark | Maintained | Buy | $11 $16 | Jul 24, 2026 |
| Benchmark | Upgraded from Hold | Buy | $11 | Apr 29, 2026 |
| TD Cowen | Maintained | Buy | $13 $14 | Apr 29, 2026 |
| Leerink Partners | Upgraded from Market Perform | Outperform | $12 $25 | Apr 29, 2026 |
| Piper Sandler | Maintained | Overweight | $12 $13 | Feb 24, 2026 |
| Needham | Maintained | Buy | $14 $15 | Feb 17, 2026 |
| Needham | Reiterated | Buy | $14 | Jan 12, 2026 |
| TD Cowen | Maintained | Buy | $10 $12 | Sep 12, 2025 |
| Stephens & Co. | Maintained | Overweight | $6.5 $11 | Sep 2, 2025 |
| Needham | Maintained | Buy | $8 $14 | Aug 29, 2025 |
| Piper Sandler | Maintained | Overweight | $12 $11 | Aug 4, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $10 $8 | Jul 30, 2025 |
| William Blair | Downgraded from Outperform | Market Perform | — | Jul 29, 2025 |
| Needham | Maintained | Buy | $8.5 $8 | Jul 29, 2025 |
| Piper Sandler | Maintained | Overweight | $18 $12 | May 6, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $17 $10 | May 1, 2025 |
| Goldman Sachs | Maintained | Buy | $15 $10 | Apr 30, 2025 |
| Leerink Partners | Downgraded from Outperform | Market Perform | $25 $9 | Apr 30, 2025 |
| Needham | Maintained | Buy | $18 $8.5 | Apr 29, 2025 |
| Goldman Sachs | Maintained | Buy | $17 $15 | Apr 17, 2025 |
| Piper Sandler | Maintained | Overweight | $21 $18 | Feb 26, 2025 |
59 filings from 17 insiders · 14 buy / 3 sell over 6m
Officers and directors of NEO, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| STONE WARRENPresident | Other | 17.6k | — | — | Oct 1, 2026 |
| STONE WARRENPresident | Other | 28.1k | — | — | Aug 21, 2026 |
| AUNAN GREGORY DOfficer | Sell | 20.0k | $16.07 | $321k | Aug 4, 2026 |
| TETRAULT LYNN A.Director | Sell | 5.3k | $11.10 | $59k | Jun 15, 2026 |
| TETRAULT LYNN A.Director | Sell | 5.3k | $11.29 | $60k | Jun 9, 2026 |
| TETRAULT LYNN A.Director | Other | 23.1k | — | — | Jun 1, 2026 |
| GREEN MARJORIE CDirector | Other | 23.0k | — | — | Jun 1, 2026 |
| GUNN NEILDirector | Other | 23.1k | — | — | Jun 1, 2026 |
| KELLY MICHAEL AARONDirector | Other | 23.1k | — | — | Jun 1, 2026 |
| PEREZ DAVID BRIANDirector | Other | 23.1k | — | — | Jun 1, 2026 |
| KENNY JOHN PDirector | Other | 5.9k | — | — | Jun 1, 2026 |
| KANOVSKY STEPHEN MICHAELDirector | Other | 23.1k | — | — | Jun 1, 2026 |
| WILLIAMS FELICIADirector | Other | 23.1k | — | — | Jun 1, 2026 |
| STONE WARRENPresident | Other | 5.8k | — | — | May 11, 2026 |
| OLIVO ALICIA CGeneral Counsel | Other | 3.9k | — | — | May 11, 2026 |
| STONE WARRENPresident | Other | 6.0k | — | — | May 1, 2026 |
| AUNAN GREGORY DOfficer | Other | 5.4k | — | — | May 1, 2026 |
| ZOOK ANTHONY PChief Executive Officer | Other | 140.5k | — | — | Apr 1, 2026 |
| STONE WARRENPresident | Other | 17.6k | — | — | Apr 1, 2026 |
| SHERMAN JEFFREY SCOTTChief Financial Officer | Other | 57.7k | — | — | Feb 23, 2026 |
No analyst notes on NEO yet.
Analyst Ratings
10 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 7 | 3 | 0 | 0 | Buy2.08 |
| 1 mo ago | 2 | 6 | 4 | 0 | 0 | Buy2.17 |
| 2 mo ago | 2 | 6 | 4 | 0 | 0 | Buy2.17 |
| 3 mo ago | 2 | 6 | 4 | 0 | 0 | Buy2.17 |
Members whose judged calls on NEO have played out most reliably.
No settled calls on NEO yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice